P1‐250: Genome‐Wide Association Study of Late‐Onset Alzheimer Disease Identifies Disease‐Associated Variants in MS4A4/MS4A6E, CD2AP, CD33, and EPHA1
The DOI matches its Crossref record.
Abstract
Late-onset Alzheimer Disease (LOAD) is a highly heritable disease (∼60-80%) with variation at APOE, CR1, CLU, PICALM, and BIN1 known to contribute to genetic susceptibility. The Alzheimer Disease Genetics Consortium (ADGC) examined data from 11,840 cases and 10,931 controls to identify genetic variants previously unobserved to be associated with LOAD. All fifteen ADGC datasets were genotyped on Illumina or Affymetrix platforms, with imputation in MACH to construct a set of common SNPs across all datasets. We examined 2,324,889 single SNP associations in a discovery stage of 8,309 LOAD cases and 7,366 cognitively normal elders (CNEs) as controls (Stage 1), followed by two replication stages (Stage 2: 3,531 LOAD cases and 3,565 CNEs; Stage 3 GERAD+ external replication: 7,650 LOAD cases and 25,839 mixed-age controls), all individuals of European ancestry. Association analysis used logistic regression for case-control data and generalized estimating equations (GEE) for family data, adjusting for population substructure. Data were analyzed using meta-analysis (M) of individual datasets and joint analysis (J) pooling data across studies. Other than the APOE region, nine distinct genomic regions yielded SNP assocations with P-value from meta-analysis (PM) or from joint analysis (PJ) = 10 in combined Stage 1+2 analysis, including regions with previously confirmed associations such as CR1 (rs6701713; PM = 4.6×10), CLU (rs1532278; PM = 8.3×10), and PICALM (rs561655; PM = 7.0×10) as well as the previously reported BIN1 (rs7561528; PM = 4.0×10). Five of the regions identified had not previously demonstrated SNP associations with genome-wide statistical significance (P = 5×10); these included the MS4A4A locus (rs4938933; PM = 1.7×10), CD2AP (rs9349407; PM = 1.0×10), EPHA1 (rs11767557; PM = 2.4×10), and CD33 (rs3865444;PM = 1.1×10). In combined Stage 1+2 analysis, we also observed highly significant association for the ABCA7 SNP rs3752246 (PM = 5.8×10) encoding a missense variant (G1527A) potentially altering ABCA7 protein function. We identified new SNP associations with LOAD at MS4A4A, CD2AP, EPHA1, CD33, and ABCA7, which brings the total of consistently replicated loci associated with LOAD risk to 10 (APOE, CR1, CLU, PICALM, BIN1, EPHA1, MS4A, CD33, CD2AP, and ABCA7). These findings confirm the emerging consensus that common genetic variation plays a significant role in the etiology of LOAD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Beecham, G. W., Hamilton, K., Naj, A. C., Martin, E. R., Huentelman, M., Myers, A. J., Corneveaux, J. J., Hardy, J., Vonsattel, J.-P., Younkin, S. G., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004606 · Cited by 343
Self-citationAlzheimer’s disease: analyzing the missing heritability
Ridge, P. G., Mukherjee, S., Crane, P. K., Kauwe, J. S. K., & Alzheimer’s Disease Genetics Consortium (2013) · PLoS ONE · doi:10.1371/journal.pone.0079771 · Cited by 328
“Quality control of the imputed data was performed as described by Naj et al. 2011 [20].”
MethodMicroglial Phagocytosis: A Disease-Associated Process Emerging from Alzheimer’s Disease Genetics
Podleśny-Drabiniok, A., Marcora, E., & Goate, A. M. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.10.002 · Cited by 211
Targeting microglia for the treatment of Alzheimer’s Disease
Wes, P. D., Sayed, F. A., Bard, F., & Gan, L. (2016) · Glia · doi:10.1002/glia.22988 · Cited by 185
“CD33 falls into the category of genetic risk factors that are highly prevalent in the population ( 40% minor allele frequency) but that confer a small genetic risk (Hollingworth et al., 2011; Naj et al., 2011a,b).”
BackgroundWes, P. D., Holtman, I. R., Boddeke, E. W. G. M., Möller, T., & Eggen, B. J. L. (2016) · Glia · doi:10.1002/glia.22866 · Cited by 167
Metadata
- Authors
- Naj, A., Jun, G., Buros, J., Gallins, P., Farrer, L., Haines, J., Pericak‐Vance, M., Schellenberg, G., & The Alzheimer's Disease Genetics Consortium
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2011-07
- Volume
- 7
- Issue
- 4S_Part_6
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W1975470883
- Cited by
- 36
- References
- 0
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: P1‐250: Genome‐Wide Association Study of Late‐Onset Alzheimer Disease Identifies Disease‐Associated Variants in MS4A4/MS4A6E, CD2AP, CD33, and EPHA1. https://app.cochat.ai/papers/10.1016/j.jalz.2011.05.530
- The paper
- Naj, A., Jun, G., Buros, J., Gallins, P., Farrer, L., Haines, J., Pericak‐Vance, M., Schellenberg, G., & The Alzheimer's Disease Genetics Consortium. (2011). P1‐250: Genome‐Wide Association Study of Late‐Onset Alzheimer Disease Identifies Disease‐Associated Variants in MS4A4/MS4A6E, CD2AP, CD33, and EPHA1. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2011.05.530
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.